Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation

7 Aug 2018

Abstract excerpt

< .001). The overall survival probability was 60% at 3 years after diagnosis of subsequent solid cancer and differed according to cancer type. Development of most solid cancers was associated with an increased risk of subsequent mortality after HCT. Subsequent solid cancers accounted for 76% of causes of death. Overall survival probabilities adjusted for age, sex, and year of diagnosis were lower in the HCT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Hematopoietic Stem Cell Transplantation
Share to Polyomavirus and related diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30087108
DOI: 10.1182/bloodadvances.2018020966

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantationPMID 30087108Read ↗

Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European PatientsSemantic proximity Read ↗

Subsequent Cancers following Non-myeloablative Conditioning for Allogeneic Hematopoietic Cell TransplantationSemantic proximity Read ↗

Solid cancers after allogeneic hematopoietic cell transplantationSemantic proximity Read ↗

Solid tumor second primary neoplasms: who is at risk, what can we do?Semantic proximity Read ↗

Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan-cancer analysis of the SEER database.Semantic proximity Read ↗

Subsequent malignant neoplasms of the kidney after treatment of primary malignancy during childhood: Analysis of Surveillance, Epidemiology, and End ResultsSemantic proximity Read ↗

Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma.Semantic proximity Read ↗

Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell TransplantsSemantic proximity Read ↗

Second malignant neoplasms after successful treatment of childhood cancers.Semantic proximity Read ↗

Risk of second primary cancers after malignant mesothelioma and vice versa.Semantic proximity Read ↗

Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.Semantic proximity Read ↗

Ongoing equipoise contributes to unchanged outcomes and significant morbidity following post-transplant cutaneous squamous cell carcinoma: A Multicentre Cohort StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.